12:00 AM
 | 
Oct 15, 2012
 |  BC Week In Review  |  Company News  |  Deals

Amarantus BioSciences Inc., Memory Dx deal

Memory Dx granted Amarantus an exclusive option to license Memory Dx's LymPro Test to aid in the diagnosis of Alzheimer's disease. Memory Dx received 500,000 restricted...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >